Dr. Arash Ash Alizadeh MD, PHD?
Update this Profile
Dr. Arash Ash Alizadeh MD, PHD, Hematologist (Blood Specialist)
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Arash Ash Alizadeh MD, PHD

Hematologist-Oncologist | Hematology & Oncology

5/5(2)
875 Blake Wilbur Drive Stanford University Stanford CA, 94305
Rating

5/5

About

Dr. Arash Alizadeh is a hematologist oncologist practicing in Stanford, CA. Dr. Alizadeh specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Board Certification

Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 2009

Internal MedicineAmerican Board of Internal MedicineABIM- Hematology- 2009

Provider Details

MaleEnglish 14 years of experience

Fellowships

  • Stanford University School of Medicine,Stanford, Ca, United States   2009

Publications

  • JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONAssociation of a Leukemic Stem Cell Gene Expression Sigture With Clinical Outcomes2010
  • NEW ENGLAND JOURL OF MEDICINEMolecular Outcome Prediction in Diffuse Large-B-Cell Lymphoma2009
  • NUCLEIC ACIDS RESEARCHSOURCE: a unified genomic resource of functiol annotations, ontologies, and gene expression data2003
  • TUREDistinct types of diffuse large B-cell lymphoma identified by gene expression profiling2000
  • Alizadeh, A., Eisen, M., Davis, R. E., Ma, C., Sabet, H., Tran, T., PoThe lymphochip: A specialized cD microarray for the genomic1999
  • BloodHigh PD-1 expression2013
  • TURE COMMUNICATIONSGermil centre protein HGAL promotes lymphoid hyperplasia2013
  • Green, M. R., Gentles, A. J., ir, R. V., Irish, J. M., Levy, R., AlizaHierarchy in Somatic Mutations Arising During Genomic Evolution0
  • Kohrt, H. E., Tian, L., Li, L., Alizadeh, A. A., Hsieh, S., Strober, SIdentification of Candidate Transcriptiol Biomarkers Associated with Chronic Graft-Versus0
  • Torchia, J. A., Ng, P. P., Chen, H., Kohrt, H. E., Marabelle, A., AlizTargeting B-Cell Lymphoma with Idiotype-Specific Peptibodies0
  • Bratman, S. V., Eclov, N. C., Modlin, L. A., Neal, J., Loo, B. W., Wu,Cell-free D as a Biomarker of Residual Disease Following Radiation Therapy for Non2012
  • AMERICAN JOURL OF PATHOLOGYCD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T2012
  • JOURL OF EXPERIMENTAL MEDICINEThe chemoattractant chemerin suppresses melanoma by recruiting tural killer cell antitumor defenses2012
  • Pachynski, R. K., Zabel, B., Tejeda, N., Monnier, J., Holzer, A. K., GThe chemoattractant chemerin as a tural tumor suppressive cytokine.0
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMThe CD47-sigl regulatory protein alpha2012
  • JOURL OF CLINICAL MICROBIOLOGYFirst Isolation of Cryptococcus uzbekistanensis from an Immunocompromised Patient with Lymphoma2012
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMThree differentiation states risk-stratify bladder cancer into distinct subtypes2012
  • HAEMATOLOGICA-THE HEMATOLOGY JOURLTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
  • Arthritis research & therapyCorrection: Specific post2012
  • ARTHRITIS RESEARCH & THERAPYSpecific post-translatiol histone modifications of neutrophil extracellular traps as immunogens2012
  • Brody, J. D., Czerwinski, D. K., Carlton, V., Moorhead, M., Zheng, J.,Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Prelimiry Results2011
  • CELL CYCLEA few good genes Simple, biologically motivated sigtures for cancer prognosis2011
  • AMERICAN JOURL OF HEMATOLOGYUtility of positron emission tomography scans in mantle cell lymphoma2011
  • HEMATOLOGICAL ONCOLOGYImpact of TET2 mutations on mR expression2011
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMProspective separation of normal and leukemic stem cells based on differential expression of TIM32011
  • CANCER RESEARCHTherapeutic Antibody Targeting of CD47 Elimites Human Acute Lymphoblastic Leukemia2011
  • SCIENCE TRANSLATIOL MEDICINECalreticulin Is the Domint Pro-Phagocytic Sigl on Multiple Human Cancers2010
  • Myklebust, J. H., Irish, J. M., Brody, J., Alizadeh, A. A., CzerwinskiNF-kappa B Sigling In Response to CpG Stratifies Mantle Cell Lymphoma Patient Outcome2010
  • AMERICAN JOURL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMB-cell sigling networks reveal a negative prognostic human lymphoma cell subset that emerges during2010
  • Alizadeh, A. A., Gentles, A. J., Plevritis, S. K., Levy, R.Gene Expression Sigture of Host Immune Response2009
  • BloodA pluripotency sigture predicts histological transformation0
  • Clinical advances in hematology & oncology : H&OEvaluation and magement of angioimmunoblastic T-cell lymphoma2008
  • LEUKEMIA & LYMPHOMADouble trouble in follicular lymphoma: A rare and unusual synergy of oncogenes in the germil center2008
  • JOURL OF CLINICAL MICROBIOLOGYDiagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan2007
  • BLOODDistinct IL-4-induced gene expression, proliferation2005
  • LEUKEMIAAID is expressed in germil center B-cell-like2004
  • NEW ENGLAND JOURL OF MEDICINEPrediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes2004
  • PLoS biologyGene expression sigture of fibroblast serum response predicts human cancer progression2004
  • PLOS BIOLOGYT cell receptor-independent basal sigling via Erk and Abl kises suppresses RAG gene expression2003
  • PLoS biologyT cell receptor-independent basal sigling via Erk and Abl kises suppresses RAG gene expression.2003
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMIndividuality and variation in gene expression patterns in human blood2003
  • N Engl J MedMolecular heterogeneity in acute rel allograft rejection identified by D microarray profiling2003
  • AMERICAN JOURL OF PATHOLOGYSoftware tools for high-throughput alysis2002
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMGenomic expression programs and the integration of the CD28 costimulatory sigl in T cell activation2002
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMTransformation of follicular lymphoma to diffuse large-cell lymphoma2002
  • BLOODThe t(14;18) defines a unique subset of diffuse large B2002
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMStereotyped and specific gene expression programs in human inte immune responses to bacteria2002
  • JOURL OF EXPERIMENTAL MEDICINERelation of gene expression phenotype to immunoglobulin mutation genotype2001
  • JOURL OF PATHOLOGYTowards a novel classification of human maligncies based on gene expression patterns2001
  • Sarwal, M., Chang, S., Barry, C., Chen, X., Alizadeh, A., Salvatierra,Genomic alysis of rel allograft dysfunction using cD microarrays2001
  • PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMOngoing immunoglobulin somatic mutation in germil center B cell-like but not in activated B cell2000
  • Boldrick, J. C., Belcher, C. E., Alizadeh, A. A., Liu, C. L., Diehn, MExploring gene expression sigtures of host responses to infection2000
  • JAMA-JOURL OF THE AMERICAN MEDICAL ASSOCIATIONExamining the living genome in health and disease with D microarrays2000
  • CURRENT OPINION IN IMMUNOLOGYGenomic-scale gene expression profiling of normal and malignt immune cells2000
  • Chan, W. C., Alizadeh, A., Eisen, M., Davis, R. E., Ma, C., Sabet, H.,Gene expression in large B-cell lymphoma using cD microarray technology.1999
  • TURE GENETICSGenome-wide alysis of D copy-number changes using cD microarrays1999
  • JOURL OF CLINICAL IMMUNOLOGYProbing lymphocyte biology by genomic-scale gene expression alysis1998
  • JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONAssociation of a Leukemic Stem Cell Gene Expression Signature With Clinical Outcomes2010
  • CellTherapeutic Antibody Targeting of CD47 Synergizes with Rituximab to Completely Eradicate Human B2010
  • CELLCD47 Is an Adverse Prognostic Factor2009
  • NEW ENGLAND JOURNAL OF MEDICINEMolecular Outcome Prediction in Diffuse Large-B-Cell Lymphoma2009
  • NUCLEIC ACIDS RESEARCHSOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data2003
  • NATUREDistinct types of diffuse large B-cell lymphoma identified by gene expression profiling2000
  • Alizadeh, A., Eisen, M., Davis, R. E., Ma, C., Sabet, H., Tran, T., PoThe lymphochip: A specialized cDNA microarray for the genomic1999
  • Clinical immunologyIdentification of gene microarray expression profiles in patients with chronic graft-versus2013
  • BloodUtility in prognostic value added by molecular profiles for diffuse large B-cell lymphoma.2013
  • LEUKEMIA & LYMPHOMARituximab use and survival after diffuse large B-cell or follicular lymphoma2013
  • BloodHierarchy in somatic mutations arising during genomic evolution2013
  • BloodHigh PD-1 expression2013
  • NATURE COMMUNICATIONSGerminal centre protein HGAL promotes lymphoid hyperplasia2013
  • Green, M. R., Gentles, A. J., Nair, R. V., Irish, J. M., Levy, R., AliHierarchy in Somatic Mutations Arising During Genomic Evolution0
  • Newman, A. M., Gentles, A. J., Plevritis, S. K., Alizadeh, A. A.Systematic Deconvolution of Hematolymphoid Tumor Transcriptomes Reveals Infiltrating Immune Cell0
  • Liu, C. L., Dai, B., Newman, A. M., Majeti, R., Alizadeh, A. A.Genome-Wide Characterization of Human Hematopoietic Progenitor Cell Heterogeneity by Expression0
  • Kohrt, H. E., Tian, L., Li, L., Alizadeh, A. A., Hsieh, S., Strober, SIdentification of Candidate Transcriptional Biomarkers Associated with Chronic Graft-Versus0
  • Torchia, J. A., Ng, P. P., Chen, H., Kohrt, H. E., Marabelle, A., AlizTargeting B-Cell Lymphoma with Idiotype-Specific Peptibodies0
  • BLOODSelf-antigen recognition by follicular lymphoma B-cell receptors2012
  • Bratman, S. V., Eclov, N. C., Modlin, L. A., Neal, J., Loo, B. W., Wu,Cell-free DNA as a Biomarker of Residual Disease Following Radiation Therapy for Non2012
  • PLOS ONERole of Smad Proteins in Resistance to BMP-Induced Growth Inhibition in B-Cell Lymphoma2012
  • AMERICAN JOURNAL OF PATHOLOGYCD137 Is Expressed in Follicular Dendritic Cell Tumors and in Classical Hodgkin and T2012
  • JOURNAL OF EXPERIMENTAL MEDICINEThe chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor2012
  • LEUKEMIA & LYMPHOMAA retrospective study evaluating the efficacy2012
  • Pachynski, R. K., Zabel, B., Tejeda, N., Monnier, J., Holzer, A. K., GThe chemoattractant chemerin as a natural tumor suppressive cytokine.0
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OThe CD47-signal regulatory protein alpha2012
  • JOURNAL OF CLINICAL MICROBIOLOGYFirst Isolation of Cryptococcus uzbekistanensis from an Immunocompromised Patient with Lymphoma2012
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OThree differentiation states risk-stratify bladder cancer into distinct subtypes2012
  • HAEMATOLOGICA-THE HEMATOLOGY JOURNALTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
  • Arthritis research & therapyCorrection: Specific post2012
  • ARTHRITIS RESEARCH & THERAPYSpecific post-translational histone modifications of neutrophil extracellular traps as immunogens2012
  • Brody, J. D., Czerwinski, D. K., Carlton, V., Moorhead, M., Zheng, J.,Immunotransplant for Mantle Cell Lymphoma: Phase I/II Study Preliminary Results2011
  • CELL CYCLEA few good genes Simple, biologically motivated signatures for cancer prognosis2011
  • EPIGENETICS & CHROMATINA proteomic approach for the identification of novel lysine methyltransferase substrates2011
  • AMERICAN JOURNAL OF HEMATOLOGYUtility of positron emission tomography scans in mantle cell lymphoma2011
  • HEMATOLOGICAL ONCOLOGYImpact of TET2 mutations on mRNA expression2011
  • CANCER CELLSurprise! HSC Are Aberrant in Chronic Lymphocytic Leukemia2011
  • BLOODPrediction of survival in diffuse large B2011
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OProspective separation of normal and leukemic stem cells based on differential expression of TIM32011
  • BLOODCD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies2011
  • CANCER RESEARCHTherapeutic Antibody Targeting of CD47 Eliminates Human Acute Lymphoblastic Leukemia2011
  • SCIENCE TRANSLATIONAL MEDICINECalreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers2010
  • Myklebust, J. H., Irish, J. M., Brody, J., Alizadeh, A. A., CzerwinskiNF-kappa B Signaling In Response to CpG Stratifies Mantle Cell Lymphoma Patient Outcome2010
  • Alizadeh, A. A., Gentles, A. J., Alencar, A. J., Kohrt, H. E., Houot, Prediction of Survival In Diffuse Large B2010
  • Kohrt, H. E., Li, L., Alizadeh, A. A., Goldstein, M. J., Strober, S., Noninvasive Prediction of Graft-Verus2010
  • Layn, K., Alizadeh, A. A., Kattah, N., Levy, S., Levy, R.Self-Antigen Recognition by the B Cell Receptors of Follicular Lymphoma2010
  • Alizadeh, A. A., Anderson, M., Kohrt, H. E., Shyam, R. M., Bangs, C. DClinical and Pathological Features of Non-Hodgkin Lymphomas Harboring Concurrent t(142010
  • AMERICAN JOURNAL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OB-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges2010
  • LEUKEMIA & LYMPHOMAExpression profiles of adult T-cell leukemia-lymphoma2010
  • LEUKEMIA RESEARCHImmunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)2010
  • Li, L., Kohrt, H., Heish, S., Alizadeh, A., Laport, G., Shizuru, J., NNoninvasive Prediction of Graft-Versus2010
  • Blood (e-Letter)Is Time of the Essence in Adult Acute Myeloid Leukemia2010
  • Chao, M. P., Alizadeh, A. A., Tang, C. Z., Myklebust, J. H., Varghese,Therapeutic Antibody Targeting of CD47 Synergizes with Rituximab to Completely Eradicate Human B2009
  • Alizadeh, A. A., Gentles, A. J., Plevritis, S. K., Levy, R.Gene Expression Signature of Host Immune Response Is Predictive of Follicular Lymphoma Patient2009
  • Alizadeh, A. A., Gentles, A. J., Alencar, A. J., Kohrt, H. E., Houot, Prediction of Survival in Diffuse Large B-Cell Lymphoma Based On the Expression of Two Genes2009
  • Kohrt, H. E., Patel, S., Ho, M., Owen, T., Majeti, R., Gotlib, J. R., Is Time of the Essence in Adult Acute Myeloid Leukemia2009
  • Alizadeh, A. A., McClellan, J. S., Gotlib, J. R., Coutre, S., Majeti, Early Mortality in Acute Promyelocytic Leukemia May Be Higher Than Previously Reported.2009
  • Myklebust, J. H., Irish, J. M., Houot, R., Brody, J., Czerwinski, D. KA Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma2009
  • Houot, R., Goldstein, M. J., Kohrt, H. E., Myklebust, J. H., Alizadeh,Therapeutic Potential of Anti-CD137 Antibody in Lymphoma2009
  • BLOODTherapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T-reg depletion2009
  • Chao, M. P., Alizadeh, A., Tang, C. Z., Jan, M., Levy, R., Majeti, R.,CD47 IS AN ADVERSE PROGNOSTIC FACTOR IN NON2009
  • BloodA pluripotency signature predicts histological transformation0
  • Clinical advances in hematology & oncology : H&OEvaluation and management of angioimmunoblastic T-cell lymphoma2008
  • Majeti, R., Chao, M. P., Alizadeh, A. A., Pang, W. W., Weissman, I. L.CD47 Is An Independent Prognostic Factor2008
  • Advani, R., Talreja, N., Tibshirani, R., Zhao, S., Alizadeh, A., BrionLMO2 Protein Expression Predicts Survival in Patients with Diffuse Large B2008
  • LEUKEMIA & LYMPHOMADouble trouble in follicular lymphoma2008
  • JOURNAL OF CLINICAL MICROBIOLOGYDiagnosis of a critical respiratory illness caused by human metapneumovirus by use of a pan2007
  • BMC GENOMICSCell-type specific gene expression profiles of leukocytes in human peripheral blood2006
  • BLOODDistinct IL-4-induced gene expression, proliferation2005
  • LEUKEMIAAID is expressed in germinal center B-cell-like2004
  • BLOODFludarabine treatment of patients with chronic lymphocytic leukemia induces a p532004
  • NEW ENGLAND JOURNAL OF MEDICINEPrediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes2004
  • PLoS biologyGene expression signature of fibroblast serum response predicts human cancer progression2004
  • LANCETRole of interleukin 6 in myocardial dysfunction of meningococcal septic shock2004
  • PLOS BIOLOGYT cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression2003
  • PLoS biologyT cell receptor-independent basal signaling via Erk and Abl kinases suppresses RAG gene expression.2003
  • ARTHRITIS AND RHEUMATISMRheumatoid arthritis is a heterogeneous disease2003
  • BLOODTransformation of follicular lymphoma to diffuse large cell lymphoma is2003
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OIndividuality and variation in gene expression patterns in human blood2003
  • BLOODHGAL is a novel interleukin-42003
  • N Engl J MedMolecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling2003
  • AMERICAN JOURNAL OF PATHOLOGYSoftware tools for high-throughput analysis2002
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OGenomic expression programs2002
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OTransformation of follicular lymphoma to diffuse large-cell lymphoma2002
  • BLOODThe t(14;18) defines a unique subset of diffuse large B2002
  • GENOME RESEARCHIn vivo regulation of human skeletal muscle gene expression by thyroid hormone2002
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OStereotyped and specific gene expression programs in human innate immune responses to bacteria2002
  • JOURNAL OF EXPERIMENTAL MEDICINERelation of gene expression phenotype to immunoglobulin mutation genotype2001
  • JOURNAL OF PATHOLOGYTowards a novel classification of human malignancies based on gene expression patterns2001
  • Sarwal, M., Chang, S., Barry, C., Chen, X., Alizadeh, A., Salvatierra,Genomic analysis of renal allograft dysfunction using cDNA microarrays2001
  • PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OOngoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell2000
  • Boldrick, J. C., Belcher, C. E., Alizadeh, A. A., Liu, C. L., Diehn, MExploring gene expression signatures of host responses to infection2000
  • JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONExamining the living genome in health and disease with DNA microarrays2000
  • CURRENT OPINION IN IMMUNOLOGYGenomic-scale gene expression profiling of normal and malignant immune cells2000
  • Genome biology'Gene shaving' as a method for identifying distinct sets of genes with similar expression patterns.2000
  • Chan, W. C., Alizadeh, A., Eisen, M., Davis, R. E., Ma, C., Sabet, H.,Gene expression in large B-cell lymphoma using cDNA microarray technology.1999
  • NATURE GENETICSGenome-wide analysis of DNA copy-number changes using cDNA microarrays1999
  • JOURNAL OF CLINICAL IMMUNOLOGYProbing lymphocyte biology by genomic-scale gene expression analysis1998

Dr. Arash Ash Alizadeh MD, PHD's Practice location

Dr. Arash Alizadeh

875 Blake Wilbur Drive Stanford University -
Stanford, CA 94305
Get Direction
New patients: 650-723-5007, 650-725-6423
Fax: 650-736-2282, 650-724-5203

Dr. Arash Ash Alizadeh MD, PHD's reviews

(2)
Write Review

Patient Experience with Dr. Alizadeh


5.0

Based on 2 reviews

Dr. Arash Ash Alizadeh MD, PHD has a rating of 5 out of 5 stars based on the reviews from 2 patients. FindaTopDoc has aggregated the experiences from real patients to help give you more insights and information on how to choose the best Hematologist-Oncologist in your area. These reviews do not reflect a providers level of clinical care, but are a compilation of quality indicators such as bedside manner, wait time, staff friendliness, ease of appointment, and knowledge of conditions and treatments.

Recommended Articles

  • New Diagnostic Tool Approved for Lymphoma

    A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...

  • Dance Mom Abby Lee Miller Diagnosed with Non-Hodgkin Lymphoma

    Abby Lee Miller, known for her brutal dance instruction and demanding style of training, is as recognized for her tirades as she is for her long-running hit reality show Dance Moms.Abby inherited the love of dance from her late mother and started her own dance company at just 14 years old. She...

  • Facts About Multiple Myeloma

    Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...

  • Treatments for Multiple Myeloma

    The cancer care crew discusses what treatment will suit you after multiple myeloma has been diagnosed and staged. The following are treatments used in multiple myeloma:...

  • What Specialists Treat Multiple Myeloma?

    If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...

  • The Lymphoma Research Foundation Announces Partnership with the Annals of Lymphoma

    The Lymphoma Research Foundation (LRF) is the nation’s largest non-profit organization for lymphoma research, and they just announced their partnership with the Annals of Lymphoma (AOL). This was all revealed in September during Blood Cancer Awareness Month. LRF is devoted to exclusively funding...

Nearby Providers

Nearest Hospitals

STANFORD HEALTH CAREl

300 PASTEUR DRIVE STANFORD CA 94305

Head north on Blake Wilbur Drive 383 ft
Turn left onto Welch Road 1270 ft
Turn left onto Pasteur Drive 55 ft
You have arrived at your destination, on the left

MENLO PARK SURGICAL HOSPITALl

570 WILLOW ROAD MENLO PARK CA 94025

Head north on Blake Wilbur Drive 357 ft
Turn right onto Welch Road 1607 ft
Turn left onto Quarry Road 1048 ft
Turn right onto Arboretum Road 1357 ft
Turn left onto Palm Drive 1622 ft
Continue straight onto University Avenue 851 ft
Continue onto University Avenue 3088 ft
Turn left onto Middlefield Road 2535 ft
Turn right onto Willow Road 3026 ft
Turn right 219 ft
You have arrived at your destination, on the right

LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl

725 WELCH ROAD PALO ALTO CA 94304

Head north on Blake Wilbur Drive 357 ft
Turn right onto Welch Road 788 ft
Turn right 348 ft
Turn left 69 ft
You have arrived at your destination, on the left